The role of gut microbiome in the complex relationship between respiratory tract infection and asthma

Abstract

Asthma is one of the common chronic respiratory diseases in children, which poses a serious threat to children's quality of life. Respiratory infection is a risk factor for asthma. Compared with healthy children, children with early respiratory infections have a higher risk of asthma and an increased chance of developing severe asthma. Many clinical studies have confirmed the correlation between respiratory infections and the pathogenesis of asthma, but the underlying mechanism is still unclear. The gut microbiome is an important part of maintaining the body's immune homeostasis. The imbalance of the gut microbiome can affect the lung immune function, and then affect lung health and cause respiratory diseases. A large number of evidence supports that there is a bidirectional regulation between intestinal flora and respiratory tract infection, and both are significantly related to the development of asthma. The changes of intestinal microbial components and their metabolites in respiratory tract infection may affect the occurrence and development of asthma through the immune pathway. By summarizing the latest advancements in research, this review aims to elucidate the intricate connection between respiratory tract infections and the progression of asthma by highlighting its bridging role of the gut microbiome. Furthermore, it offers novel perspectives and ideas for future investigations into the mechanisms that underlie the relationship between respiratory tract infections and asthma.

Winds of change a tale of: asthma and microbiome

“…However, a noteworthy challenge arises when endeavoring to amalgamate shared findings from diverse studies. While certain commonalities have been identified, their respective implications vary depending upon the contextual framework ( Barcik et al, 2020 ; Lupu et al, 2023 ; Zhao et al, 2023 ). Consequently, it has proven to be quite formidable to identify a specific taxonomic group that consistently influences or mitigates the risk factors or clinical presentations of asthma across all scenarios.…”